New Delhi, (the states. news)
PM Narendra Modi reviewed progress on
development of COVID vaccines at three research centers in Ahmedabad, Hyderabad
and Pune and held discussions with scientists there even as India recorded a
fresh spike of 41,322 new cases pushing the tally to 93,51,110. The Prime
Minister visited the Zydus Biotech Park in Ahmedabad, Bharat Biotech facility
at Hyderabad and Serum Institute of India in Pune.
After discussions with the scientists, the Prime Minister expressed
satisfaction that India’s indigenous vaccine development had progressed at such
a rapid pace so far. He spoke on how India is following sound principles of
science in the entire journey of vaccine development while also asking for
suggestions to make the vaccine distribution process better.
He stressed that India considers vaccines as not only vital to good health but
also as a global good, He said it is India’s duty to assist other countries
including neighbouring countries in the collective fight against the virus.
He asked the scientists for their opinion on how India could further improve
its regulatory process. The scientists presented an overview of how they are
also developing various new and repurposed drugs to better fight COVID-19.
At Zydus Biotech Park he reviewed progress in the development of indigenous
DNA-based COVID vaccine by Zydus Cadila.
“Visited the Zydus Biotech Park in Ahmedabad to know more about the indigenous
DNA based vaccine being developed by Zydus Cadila. I compliment the team behind
this effort for their work. Government of India is actively working with them
to support them in this journey,” the Prime Minister tweeted. He later
went to Hyderabad and visited the Bharat Biotech facility and later the Serum
Institute of India in Pune.‘’At the Bharat Biotech facility in Hyderabad, was
briefed about their indigenous COVID-19 vaccine. Congratulated the scientists
for their progress in the trials so far. Their team is closely working with
ICMR to facilitate speedy progress,” the Prime Minister’s Office (PMO)
tweeted. Bharat Biotech and the Indian Council of Medical Research (ICMR) are
involved in joint research for development of the indigenous COVID vaccine
while the Serum Institute at Pune is developing the vaccine jointly with
AstraZeneca and the Oxford University.
‘Had a good interaction with the team at Serum Institute of India. They shared
details about their progress so far on how they plan to further ramp up vaccine
manufacturing. Also took a look at their manufacturing facility,’ the Prime
Minister said after a visit to the Serum Institute.
Even as the Prime Minister reviews progress on the development of COVID
vaccine, India on Saturday witnessed a fresh spike of 41,322 new COVID cases
pushing the country’s tally to 93,51,110, the Union Health Ministry said in its
daily update here.Fatality count due to the pandemic so far has surged to
1,36,200 after 485 more lives were claimed during past 24 hours by the highly
contagious virus.
Presently, the active caseload of nCoV cases on the country stands at 4,54,940,
after witnessing a dip of 615 such cases since Friday. As on recoveries front,
there were 41,452 cured cases recorded in the past one day, pushing the total
recovered patients’ number till date to 87,59,969 across the nation.
According to the ICMR, 13,82,20,354 COVID tests have been done so far in the
country till date. (uni) (media saheb.com)